Discussion

Our plain-English summary of Discussion (The Journal of Thoracic and Cardiovascular Surgery, 2014).

The study

• Journal: The Journal of Thoracic and Cardiovascular Surgery
• Published: 2014;147(1):516
• Type of article: Comment
• Read it: PubMed · Publisher

In plain English

This item was not a research study. It was the printed transcript of a question-and-answer discussion that followed a presentation. It appeared on one page at the end of an article whose running head reads "You et al". It reported no patients and no numerical results. The discussion was about MPM, which it did not spell out; the reference list above it includes a paper on malignant pleural mesothelioma. It concerned the drug itraconazole (ITRA). The presenters had identified SMO and Gli in the Hedgehog (Hh) pathway as potential treatment targets, and the presenter said SMO is the target of ITRA. A discussant asked whether the drug's effects came from blocking this pathway. The presenter said the growth-slowing effect they observed might not all come from SMO inhibition and that what ITRA does in cancer cells remained to be determined. The presenter also noted that their cells were grown as a flat layer on plastic, which can affect Hh signaling. Finding a marker that predicts treatment response was described as the next step. Asbestos was not mentioned.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Published discussion (question-and-answer transcript) following a presentation; not itself a study
• Who was studied: No patients; the discussion refers to the presenters' laboratory cells, grown in vitro as a monolayer on plastic
• Exposure: No asbestos exposure discussed; the subject was the drug itraconazole (ITRA), whose target the presenter named as SMO in the Hedgehog pathway
• Main results:
  • The presenter (Dr Nguyen) said the antiproliferation effect they observed with ITRA might not all come from SMO inhibition, because ITRA has other effects
• The authors' conclusion: No formal conclusion; the presenter described identifying a biomarker or gene signature predictive of treatment response as the next step of the research
• Limitations the authors state:
  • The presenter said what ITRA does in cancer cells had not yet been determined
  • The presenter said the method used to grow the cells (as a monolayer on plastic) can affect Hh signaling

Topics

The National Library of Medicine indexes this study under subjects our site covers: Lung cancer, Mesothelioma.

Related studies

• Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro — M. You, J. Varona-Santos, et al. (2014)
• Gli as a novel therapeutic target in malignant pleural mesothelioma — H. Li, N. Lui, et al. (2013)
• High Expression of SMO and GLI1 Genes with Poor Prognosis in Malignant Mesothelioma — G.Y. Ma, S. Shi, et al. (2023)
• Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma — M. Meerang, K. Bérard, et al. (2016)
• Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma — Y.L. Yang, J. Ni, et al. (2015)
• Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling — J. Wu, A.M. Minikes, et al. (2019)

Browse more research in The Journal of Thoracic and Cardiovascular Surgery, or return to medical research.